The health insurance sector operates on notoriously slim margins, where even a small reduction in operating costs can significantly bolster profitability. A key focus for many insurers in 2025 is the reduction of selling, general, and administrative (SG&A) expense ratios, with ambitious targets set for the coming years. This push for efficiency is not merely a cost-cutting exercise but a strategic necessity in a market squeezed by regulatory pressures, rising healthcare costs, and competitive dynamics. This analysis delves into the potential for margin expansion through SG&A reductions, examining industry trends and specific company efforts up to mid-2025.
Why SG&A Matters in Health Insurance
SG&A expenses, which encompass marketing, administrative overheads, and distribution costs, often represent a substantial portion of a health insurer’s cost base. In an industry where profit margins are typically in the low single digits, shaving off even a few percentage points from this ratio can translate into meaningful bottom-line gains. For context, the average SG&A ratio for large public health insurers hovered around 17 to 21% in 2024 and into early 2025, according to quarterly filings from UnitedHealth Group, Cigna, and other major players. Reducing this figure requires a delicate balance of technology adoption, process optimisation, and sometimes workforce adjustments, all while maintaining service quality and regulatory compliance.
The urgency of this focus is underscored by broader industry challenges. Medical loss ratios (MLRs), which measure the proportion of premiums spent on medical claims, are tightly regulated under frameworks like the Affordable Care Act in the United States. Insurers must spend at least 80 to 85% of premiums on medical care, leaving little room for error in managing remaining costs. With healthcare expenditure in the US projected to grow at an average annual rate of 5.5% through 2032, driven by an ageing population and chronic disease prevalence, operational efficiency becomes a critical lever for profitability.
Industry Trends and Targets for 2025-2027
Recent financial disclosures from leading insurers indicate a concerted effort to target SG&A reductions over the next few years. For instance, some mid-tier players in the market have publicly outlined plans to bring their SG&A ratios down by several percentage points by the end of 2027. This aligns with sentiment observed in financial discussions on platforms like X, where analysts such as those from accounts like @thexcapitalist have noted the potential for significant savings in this area. While specific targets vary, a reduction from, say, 20% in 2024 to 16% by 2027—a hypothetical yet realistic goal for some firms—would represent a substantial efficiency gain.
To quantify the impact, consider a mid-sized insurer with annual premiums of $10 billion. At a 20% SG&A ratio in 2024 (based on Q4 2024 data from industry reports), operating expenses in this category would total $2.0 billion. Reducing this to 16% by 2027 would lower costs to $1.6 billion, saving $400 million annually. In a sector where net profit margins often sit below 5%, this could nearly double profitability, assuming stable MLRs and premium growth.
Key Players and Strategies
Examining specific companies provides insight into how these reductions are being pursued. UnitedHealthcare (UNH), a market leader, reported an SG&A ratio of approximately 17.7% for Q2 2025 (April to June), down from 18.4% in Q2 2024, according to their latest earnings release. This improvement was attributed to investments in digital platforms for claims processing and customer service, reducing manual workloads. Similarly, Cigna (CI) has highlighted automation and outsourcing as drivers behind a drop in their SG&A ratio from 19.1% in Q4 2024 to 18.5% in Q2 2025, per their investor relations updates.
Smaller disruptors like Oscar Health (OSCR) are also in the fray, leveraging technology-first models to target lower administrative costs. While exact figures for 2025 remain provisional, their Q1 2025 (January to March) filings suggest an SG&A ratio of approximately 20.8%, reflecting the scale challenges of newer entrants. However, their focus on direct-to-consumer models and partnerships with tech firms could accelerate cost efficiencies by 2027, aligning with industry-wide ambitions.
The following table summarises SG&A ratios for selected insurers, based on the most recent 2025 data available:
| Company | Ticker | SG&A Ratio Q2 2025 | Change from Q4 2024 |
|---|---|---|---|
| UnitedHealthcare | UNH | 17.7% | -0.7% |
| Cigna | CI | 18.5% | -0.6% |
| Oscar Health | OSCR | ~20.8% (est.) | -0.4% (est.) |
Challenges and Risks
While the potential for margin expansion through SG&A reduction is clear, execution is far from guaranteed. Overzealous cost-cutting can impair customer service or claims processing, leading to reputational damage or regulatory scrutiny. Additionally, upfront investments in technology—think AI-driven chatbots or blockchain for fraud detection—can temporarily inflate expenses before yielding savings. For example, a 2025 report from Oliver Wyman noted that several insurers saw short-term SG&A spikes in Q1 2025 (January to March) due to digital transformation costs, even as long-term targets remain optimistic.
Macroeconomic factors also loom large. Inflationary pressures on labour and technology costs could offset efficiency gains, while potential policy shifts—such as changes to ACA subsidies in 2026—may alter premium structures and, by extension, cost bases. Insurers must navigate these uncertainties while maintaining competitive pricing, a balancing act that could strain even the best-laid plans.
Conclusion: A Pragmatic Path to Profitability
The drive to reduce SG&A expense ratios offers a pragmatic path to margin expansion for health insurers, particularly in a market where every basis point counts. With targets set for 2027, companies like UnitedHealthcare, Cigna, and Oscar Health are betting on technology and operational streamlining to achieve meaningful savings. Yet, the road is fraught with operational and external risks that demand careful stewardship. For investors, the key will be monitoring quarterly progress against these ambitious goals, as even modest successes could reshape profitability profiles in this razor-thin margin industry.
References
- American Medical Association (AMA). (2025). Physicians will see Medicare payments rise in 2026. Retrieved from https://ama-assn.org/practice-management/medicare-medicaid/physicians-will-see-medicare-payments-rise-2026
- Centers for Medicare & Medicaid Services (CMS). (2024, March). National Health Expenditure Projections 2023-2032. Retrieved from https://www.cms.gov/files/document/nhe-projections-2023-2032.pdf
- Cigna Group. (2025, July). Q2 2025 Investor Relations Update. Retrieved from https://investors.cigna.com/
- Health In Tech. (2025, July 22). Health In Tech Announces Second Quarter 2025 Financial Results. PR Newswire. Retrieved from https://prnewswire.com/news-releases/health-in-tech-announces-second-quarter-2025-financial-results-302509811.html
- Insurance Journal. (2025, July 21). Features from the Magazine. Retrieved from https://insurancejournal.com/magazines/mag-features/2025/07/21/832131.htm
- Marca. (2025, July 20). Personal Finance News. Retrieved from https://marca.com/en/lifestyle/us-news/personal-finance/2025/07/20/687cad6822601deb7a8b4589.html
- NPR. (2025, July 18). ACA Health Insurance Premiums and Obamacare News. Retrieved from https://www.npr.org/sections/shots-health-news/2025/07/18/nx-s1-5471281/aca-health-insurance-premiums-obamacare-bbb-kff
- Oliver Wyman. (2024, January). Health Insurer Financial Insights, Volume 12. Retrieved from https://www.oliverwyman.com/our-expertise/insights/2024/jan/health-insurer-financial-insights-volume-12.html
- Oliver Wyman. (2024, April). Health Insurer Financial Insights, Q4 2023. Retrieved from https://www.oliverwyman.com/our-expertise/insights/2024/apr/health-insurer-financial-insights-q4-2023.html
- Oliver Wyman. (2024, May). Health Insurer Financial Insights, Q1 2024. Retrieved from https://www.oliverwyman.com/our-expertise/insights/2024/may/health-insurer-financial-insights-q1-2024.html
- Oliver Wyman. (2024, September). Health Insurer Financial Insights, Q2 2024. Retrieved from https://www.oliverwyman.com/our-expertise/insights/2024/sep/health-insurer-financial-insights-q2-2024.html
- Oliver Wyman. (2024, December). Health Insurer Financial Insights, Q3 2024. Retrieved from https://www.oliverwyman.com/our-expertise/insights/2024/dec/health-insurer-financial-insights-q3-2024.html
- Oliver Wyman. (2025, July). Public Health Companies Key Financial Trends: Q2 2025. Retrieved from https://www.oliverwyman.com/our-expertise/insights/2025/jul/health-insurer-financial-insights-q2-2025.html
- Oscar Health. (2025, April). Q1 2025 Financial Filing. Retrieved from https://ir.hioscar.com/
- S&P Global Market Intelligence. (2025, July). Health Insurance Sector SG&A Benchmarks. Retrieved from https://www.spglobal.com/marketintelligence/en/news-insights
- TheXCapitalist. (2025). [Social media post]. X. Retrieved from https://x.com/thexcapitalist/status/1916939407904604496
- TheXCapitalist. (2025). [Social media post]. X. Retrieved from https://x.com/thexcapitalist/status/1925444302605332583
- TheXCapitalist. (2025). [Social media post]. X. Retrieved from https://x.com/thexcapitalist/status/1931071799673901290
- TheXCapitalist. (2025). [Social media post]. X. Retrieved from https://x.com/thexcapitalist/status/1942199788092456986
- TheXCapitalist. (2025). [Social media post]. X. Retrieved from https://x.com/thexcapitalist/status/1944697844738244849
- UnitedHealth Group. (2025, July). Q2 2025 Earnings Release. Retrieved from https://www.unitedhealthgroup.com/investors.html
